Lumicell, based in Newton, MA, is a pioneering company at the forefront of transforming breast cancer surgery through innovative fluorescence imaging technology. Their investigational system is designed to illuminate residual breast cancer in real time, revolutionizing the standard of care in cancer surgery.
With a focus on enhancing intraoperative detection of cancerous tissue, Lumicell's technology has the potential to significantly impact the current landscape of breast cancer surgery. Their recent advancements, including pivotal trial results and FDA submissions, highlight their commitment to advancing the field of cancer surgery.
Generated from the website